Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.

類似資料

• Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo.
  著者:: Pardridge, W M, 等
  出版事項: (1995)
• Treatment of Alzheimer’s Disease and Blood–Brain Barrier Drug Delivery
  著者:: Pardridge, William M.
  出版事項: (2020)
• Peptide delivery to the brain via adsorptive-mediated endocytosis: Advances with SynB vectors
  著者:: Drin, Guillaume, 等
  出版事項: (2002)
• Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex.
  著者:: Saito, Y, 等
  出版事項: (1995)
• Brain drug delivery of small molecules using immunoliposomes
  著者:: Huwyler, Jörg, 等
  出版事項: (1996)